Ziprasidone
- Product NDC
- 59762-1006
- 11-digit product format
- 597621006
- Labeler code
- 59762
- Product ID
- 59762-1006_7ed20469-8ba9-41cf-8d36-ffca3b728dc6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ziprasidone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Greenstone LLC
- Application
- NDA020825
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2021-11-03
- Marketing end
- 0000-00-00
- Substance
- ZIPRASIDONE HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59762-1006 | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE) CAPSULE ZIPRASIDONE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 27 | Legacy NDC | 20250504_315e24c2-2f8c-47d9-b1b1-ce006646098a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59762-1006-1 | 59762100601 | 60 CAPSULE in 1 BOTTLE (59762-1006-1) | 60 capsule | 2021-11-03 | 0000-00-00 | No | No | Current |